预测指尖截肢患者复合移植存活率的因素;系统性审查和元分析
Ali Mohamed Elameen1, Asmaa Ali Dahy2, Ahmed Abu-Elsoud3
1Department of Plastic and Reconstructive Surgery, El-Sahel Teaching Hospital, Cairo, Egypt.
Journal of orthopaedic surgery and research
|November 19, 2024
概括
复合体移植是指尖截肢的可行治疗方法,显示72.8%的存活率. 年轻的年龄和更远端的截肢改善了患者的复合移植存活率.
科学领域:
- 整形外科手术 整形外科手术
- 创伤外科 手术 创伤外科
- 再生医学是一种再生医学.
背景情况:
- 指尖截肢是常见的紧急伤害.
- 复合移植提供了一个非微手术的解决方案,以保持数字长度,而不会导致捐赠者部位的疾病.
- 了解影响复合移植成功的因素至关重要.
研究的目的:
- 为了确定与复合移植存活相关的患者相关,创伤相关和截肢相关的因素.
- 分析指尖截肢中复合体移植的成功率.
主要方法:
- 对10项临床研究进行了全面的元分析.
- 在12个数据库中进行文献搜索,截至2023年7月.
- 包括研究比较幸存者与非幸存者的复合移植的变量,以及对预测因素的单臂研究.
主要成果:
- 分析包括720个指尖,整体复合移植的生存率为72.8%.
- 年龄较小 (OR 2.31) 和第I级截肢 (OR 0.31) 与成功移植有显著的关联.
- 没有观察到移植时间对存活率的显著影响 (P=0.449).
结论:
- 复合移植是创伤性指尖截肢后恢复美学功能指的有效程序.
- 在年轻的患者和那些有更远端截肢的患者中观察到更高的生存率.
- 这种技术为数字重建提供了一个可行的选择.
更多相关视频
05:34A Reliable Porcine Fascio-Cutaneous Flap Model for Vascularized Composite Allografts Bioengineering Studies
Published on: March 31, 2022
2.3K
10:33Vascularized Composite Hand Allograft Procurement and Preparation for Distal and Proximal Forearm Allotransplantation: A Stepwise Approach
Published on: May 23, 2025
101
相关概念视频
Actuarial Approach
384
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
384
Kaplan-Meier Approach
792
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
792
Comparing the Survival Analysis of Two or More Groups
712
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
712
Cancer Survival Analysis
863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863
